278 results on '"Pesce, Giampaola"'
Search Results
2. Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective
3. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New
4. Neurological long-COVID in the outpatient clinic: Two subtypes, two courses
5. Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature
6. Iodoprophylaxis and thyroid autoimmunity: an update
7. Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies.
8. Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
9. Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report
10. Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
11. Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
12. Choosing Wisely in autoimmunologia: le 5 Proposte del Gruppo di Studio in Autoimmunologia della SIPMeL
13. Acetylcholine receptor and muscle-specific tyrosine kinase antibodies detection: is it time for a change?
14. Nutrizione iodica e autoimmunità tiroidea: un prezzo da pagare?
15. Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
16. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets
17. Comparison of current methods for anti‐dsDNA antibody detection and reshaping diagnostic strategies
18. Evidence for charge-based mimicry in anti dsDNA antibody generation
19. Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor in sera from patients with blistering diseases: possible pathophysiological implications?
20. The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics
21. Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection
22. The importance of tissue-based assays when performing neural antibody testing for suspected paraneoplastic neurologic syndromes
23. Current technologies for anti-ENA antibody detection: State-of-the-art of diagnostic immunoassays
24. Evidence for charge-based mimicry in anti dsDNA antibody generation
25. Co-Stimulatory Molecules in Graves’ Disease
26. Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015
27. Raccomandazioni per l’utilizzo del test di attivazione dei basofili nella diagnosi delle malattie allergiche
28. Linee guida per la diagnosi di laboratorio e istologica della malattia celiaca. Revisione 2015
29. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm
30. Patients With Suspected Severe Adverse Reactions to COVID-19 Vaccination Admitted to Intensive Care Unit: A Case Report
31. Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor (LAIR) in sera from patients with blistering diseases: possible pathophysiological implications?
32. Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica
33. Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells
34. Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis
35. Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation
36. A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection
37. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study
38. Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis
39. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis
40. The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
41. Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism
42. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
43. Improving laboratory diagnostics in myasthenia gravis
44. Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation
45. Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency.: A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays
46. Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems
47. Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy
48. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis
49. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study
50. Tailoring B cell depletion therapy in MS according to memory B cell monitoring
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.